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Case Presentation
In January and February 1998, nine children (in one family) and their mother were exposed to vapors of metallic mercury in their apartment in Yonkers, New York. The apparent source was a neighbor's business, where mercury-filled amulets were reportedly prepared for practitioners of the AfroCaribbean religion Santeria. The oldest child found a 6-oz vial of mercury on the neighbor's porch. Over the next several days, the children played a game in which they hit a large globule of mercury with a hammer and observed its dispersion across a wooden floor. Mercury was then tracked throughout the apartment. The mother attempted over the next week to remove the mercury with a vacuum deaner, but only dispersed it further.
The mother took the children to a pediatrician in Yonkers, who promptly obtained urine samples for mercury analysis. After finding elevated levels of mercury in the samples, he referred the children to the Pediatric Environmental Health Specialty Unit of the Mount Sinai Hospital where all nine were hospitalized. On admission, we did not detect tremor, other neurologic abnormalities, or other signs of mercury poisoning in any of the children. To prevent development of neurotoxicity, we initiated treatment of all nine children with oral meso-2,3-dimercaptosuccinic acid (DMSA). We collected 24-hr urine samples for mercury and creatinine determinations on each child throughout the admission and periodically after discharge.
Pretreatment urinary mercury levels ranged from 61 to 1,213 pg/g creatinine, with a geometric mean of 214.3 pg/g creatinine ( Figure 1) ; the upper limit of normal recommended by the World Health Organization (WHO) is 50 pg mercury/g creatinine (1) . Initially, the children were treated with 30 mg/kg/day DMSA for 5 days. The geometric mean of all measurements obtained during inpatient chelation rose by 268% above baseline to 573.2 pg mercury/g creatinine (p < 0.0005). The children were then discharged and continued to receive treatment with 20 mg/kg/day DMSA at home for 2 more weeks. Six weeks after discharge all nine children showed reduced urine mercury levels ranging from 71 to 239 pg/g creatinine.
The geometric mean of these follow-up levels (day 54 after initial chelation) was 102.1 pg mercury/g creatinine, which was 17.8% of the geometric mean level during inpatient treatment (p < 0.0005) and 47.6% of the baseline level (p < 0.001). Because the followup values still exceeded 50 pg mercury/g creatinine, we prescribed an additional 2-week course of DMSA for all nine children. Urine mercury levels obtained several months later (day 261 after initial chelation) had dropped to 27.4 pg/g creatinine. At this point, two of the children (cases #3 and #4) still had levels > 50 pg mercury/g creatinine, and they received a final course of DMSA chelation. We learned that the family, who had been relocated, had brought along a mercury-contaminated couch from their old apartment. This source, which may have contributed to the two persistently elevated levels, was removed. Twelve months after initial chelation, urine mercury levels in these two children were 11 and 9 pg/g creatinine ( Table 1) .
Discussion
Metallic mercury is toxic to the nervous system, kidneys, and skin (2) . The (6) . In addition, children have a natural fascination with the liquid properties of metallic mercury. The information available on the detrimental neurologic effects to children of low-level lead exposure (7, 8) heightens concern about the potential of metallic mercury to be a pediatric neurotoxin at relatively low-dose exposure.
Inhalation is the most common route of pediatric exposure to metallic mercury. At room temperature, mercury exerts a significant vapor pressure, and approximately 80% of inhaled mercury vapor is retained in the body (9) . Infants and young children are at particularly high risk of exposure to mercury vapor because they tend to play near to the ground where the heavier-than-air vapor settles (10) . Neither ingestion nor percutaneous This paper represents, to our knowledge, the largest published clinical case series describing the use of oral DMSA for the treatment of overexposure to metallic mercury in children. Our data on the rapid increase of mercury diuresis immediately following initiation of oral chelation therapy with DMSA argue that DMSA is an effective chelating agent for treatment of pediatric overexposure to mercury. Without treatment, the children would be expected to undergo a much slower diuresis, with steadily declining urine mercury levels over a period that is consistent with the half-life of metallic mercury (roughly 1-2 months) (22) . These data are also consistent with previous studies that showed DMSA to be efficacious in the treatment of mercury poisoning in both animals and humans (19) (20) (21) .
Our study contained no untreated comparison group. Although it would have been interesting scientifically to compare mercury diuresis between treated and untreated children, the threat of neurotoxicity was too great in these children, with their highly elevated urine mercury levels, to justify withholding DMSA.
We would, ideally, have wished to compare DMSA to DMPS in this study to An unresolved issue in the medical management of pediatric metallic mercury exposure is the level of mercury in urine that should be considered a trigger for initiation of chelation therapy. Symptoms of metallic mercury poisoning may first appear in children at mercury levels of 50-100 pg/g creatinine, and tremor is typically the first symptom observed (23) . Unfortunately, detailed epidemiologic studies such as those undertaken to assess dose-response relationships in subclinical lead poisoning in children (7, 8, 24) have not yet been performed in the case of subdinical mercury exposure. Therefore, we recommend that treatment should be initiated in children with urine mercury levels 2 50 pg/g creatinine, as recommended by the WHO (1). This recommendation should be refined through further study.
Another unresolved question is whether the manifestations of mercury intoxication can be reversed by chelation therapy. Preliminary studies in occupationally exposed adults suggest that the effects of adult mercury poisoning are reversible with treatment (25) . However, extensive studies of the chronic effects of lower level metallic mercury poisoning have not been undertaken in adults, and even less research has been done in children. Therefore, we recommend that chelation therapy be administered as soon as possible after the diagnosis of overexposure to metallic mercury in the hope that it will minimize the long-term impact of mercury intoxication, although the effectiveness of this method has not been proven. If possible, neurodevelopmental testing may be indicated at the time of exposure and periodically afterward to assess the possibility of residual neurobehavioral impairment.
Conclusion
This case along with other recent cases of pediatric poisoning with metallic mercury remind us of the importance of primary prevention of mercury exposure. Overexposure to mercury is not a rare occurrence. Steps should be taken to limit the availability of mercury. Pediatric practitioners should warn parents and children about the hazards of playing with this perennially attractive but always dangerous metal. If exposure to metallic mercury is suspected, urine samples should be obtained for both mercury and creatinine determinations. Children with urine mercury levels > 50 pg/g creatinine should be considered for oral chelation even if they are asymptomatic.
